{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T01:20:12Z","timestamp":1791422412018,"version":"4.3.3"},"reference-count":30,"publisher":"Frontiers Media SA","funder":[{"DOI":"10.13039\/501100004963","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["304875"],"award-info":[{"award-number":["304875"]}],"id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000342","name":"Society for General Microbiology","doi-asserted-by":"publisher","award":["Harry Smith vacation scholarship"],"award-info":[{"award-number":["Harry Smith vacation scholarship"]}],"id":[{"id":"10.13039\/501100000342","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"DOI":"10.3389\/fmicb.2016.01317","type":"journal-article","created":{"date-parts":[[2016,9,8]],"date-time":"2016-09-08T23:12:14Z","timestamp":1473376334000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":75,"title":["Detection of Low Frequency Multi-Drug Resistance and Novel Putative Maribavir Resistance in Immunocompromised Pediatric Patients with Cytomegalovirus"],"prefix":"10.3389","volume":"7","author":[{"given":"Charlotte J.","family":"Houldcroft","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josephine M.","family":"Bryant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel P.","family":"Depledge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben K.","family":"Margetts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Simmonds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanos","family":"Nicolaou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena J.","family":"Tutill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Austen J. J.","family":"Worth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen D.","family":"Marks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Veys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Whittaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Breuer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2016,9,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1111\/j.1600-6143.2007.01910.x","article-title":"Oral valganciclovir is noninferior to intravenous ganciclovir for the treatment of cytomegalovirus disease in solid organ transplant recipients","volume":"7","author":"Asberg","year":"2007","journal-title":"Am. J. Transplant."},{"key":"B2","doi-asserted-by":"publisher","first-page":"5711","DOI":"10.1182\/blood-2008-10-143560","article-title":"How we treat cytomegalovirus in hematopoietic cell transplant recipients","volume":"113","author":"Boeckh","year":"2009","journal-title":"Blood"},{"key":"B3","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1002\/rmv.574","article-title":"Cytomegalovirus UL97 mutations in the era of ganciclovir and maribavir","volume":"18","author":"Chou","year":"2008","journal-title":"Rev. Med. Virol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1128\/AAC.01177-08","article-title":"Diverse cytomegalovirus UL27 mutations adapt to loss of viral UL97 kinase activity under maribavir","volume":"53","author":"Chou","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"B5","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.jcv.2011.01.004","article-title":"Phenotypic diversity of cytomegalovirus DNA polymerase gene variants observed after antiviral therapy","volume":"50","author":"Chou","year":"2011","journal-title":"J. Clin. Virol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1097\/QCO.0000000000000170","article-title":"Approach to drug-resistant cytomegalovirus in transplant recipients","volume":"28","author":"Chou","year":"2015a","journal-title":"Curr. Opin. Infect. Dis."},{"key":"B7","doi-asserted-by":"publisher","first-page":"6588","DOI":"10.1128\/AAC.01623-15","article-title":"Rapid in vitro evolution of human cytomegalovirus UL56 mutations that confer letermovir resistance","volume":"59","author":"Chou","year":"2015b","journal-title":"Antimicrob. Agents Chemother."},{"key":"B8","doi-asserted-by":"publisher","first-page":"4697","DOI":"10.1128\/AAC.03214-14","article-title":"Improved detection of emerging drug-resistant mutant cytomegalovirus subpopulations by deep sequencing","volume":"58","author":"Chou","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"B9","doi-asserted-by":"publisher","first-page":"4160","DOI":"10.1128\/AAC.00736-07","article-title":"Growth and drug resistance phenotypes resulting from cytomegalovirus DNA polymerase region III mutations observed in clinical specimens","volume":"51","author":"Chou","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"B10","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1086\/338362","article-title":"Cytomegalovirus UL97 phosphotransferase mutations that affect susceptibility to ganciclovir","volume":"185","author":"Chou","year":"2002","journal-title":"J. Infect. Dis."},{"key":"B11","doi-asserted-by":"publisher","first-page":"9492","DOI":"10.1128\/JVI.79.15.9492-9502.2005","article-title":"Frequent coinfection of cells explains functional in vivo complementation between cytomegalovirus variants in the multiply infected host","volume":"79","author":"Cicin-Sain","year":"2005","journal-title":"J. Virol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/j.1600-6143.2011.03766.x","article-title":"High incidence of anticytomegalovirus drug resistance among D+R- kidney transplant recipients receiving preemptive therapy","volume":"12","author":"Couzi","year":"2012","journal-title":"Am. J. Transplant."},{"key":"B13","doi-asserted-by":"publisher","first-page":"e27805","DOI":"10.1371\/journal.pone.0027805","article-title":"Specific capture and whole-genome sequencing of viruses from clinical samples","volume":"6","author":"Depledge","year":"2011","journal-title":"PLoS ONE"},{"key":"B14","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.jcv.2016.04.017","article-title":"Contribution of next generation sequencing to early detection of cytomegalovirus UL97 emerging mutants and viral subpopulations analysis in kidney transplant recipients","volume":"80","author":"Garrigue","year":"2016","journal-title":"J. Clin. Virol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"4019","DOI":"10.1128\/AAC.00334-11","article-title":"Recombinant phenotyping of cytomegalovirus UL54 mutations that emerged during cell passages in the presence of either ganciclovir or foscarnet","volume":"55","author":"Gilbert","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"B16","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.csbj.2015.01.003","article-title":"Antiviral drug- and multidrug resistance in cytomegalovirus infected SCT patients","volume":"13","author":"G\u00f6hring","year":"2015","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"B17","doi-asserted-by":"publisher","first-page":"7195","DOI":"10.1128\/JVI.00475-10","article-title":"Deep sequencing reveals highly complex dynamics of human cytomegalovirus genotypes in transplant patients over time","volume":"84","author":"G\u00f6rzer","year":"2010","journal-title":"J. Virol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.antiviral.2011.08.019","article-title":"Resistance to maribavir is associated with the exclusion of pUL27 from nucleoli during human cytomegalovirus infection","volume":"92","author":"Hakki","year":"2011","journal-title":"Antiviral Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1093\/jac\/dkq368","article-title":"Drug-resistant cytomegalovirus in transplant recipients: a French cohort study","volume":"65","author":"Hantz","year":"2010","journal-title":"J. Antimicrob. Chemother."},{"key":"B20","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1038\/bmt.2012.221","article-title":"Impact of viral reactivations in the era of pre-emptive antiviral drug therapy following allogeneic haematopoietic SCT in paediatric recipients","volume":"48","author":"Hiwarkar","year":"2013","journal-title":"Bone Marrow Transplant."},{"key":"B21","doi-asserted-by":"publisher","first-page":"813","DOI":"10.2217\/fvl.15.58","article-title":"Sequencing drug-resistant cytomegalovirus in pediatric patients: toward personalized medicine","volume":"10","author":"Houldcroft","year":"2015","journal-title":"Future Virol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1128\/AAC.01726-13","article-title":"Human cytomegalovirus UL97 kinase is involved in the mechanism of action of methylenecyclopropane analogs with 6-ether and -thioether substitutions","volume":"58","author":"Komazin-Meredith","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1017\/S0950268813002720","article-title":"A cohort study in university students: investigation of risk factors for cytomegalovirus infection","volume":"142","author":"Patrick","year":"2014","journal-title":"Epidemiol. Infect."},{"key":"B24","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/1743-422x-5-47","article-title":"Severe cytomegalovirus infection in apparently immunocompetent patients: a systematic review","volume":"5","author":"Rafailidis","year":"2008","journal-title":"Virol. J."},{"key":"B25","doi-asserted-by":"publisher","first-page":"3700","DOI":"10.1128\/JCM.01605-13","article-title":"Detection of cytomegalovirus drug resistance mutations by next-generation sequencing","volume":"51","author":"Sahoo","year":"2013","journal-title":"J. Clin. Microbiol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1093\/infdis\/jit475","article-title":"High rate of cytomegalovirus drug resistance among patients receiving preemptive antiviral treatment after haploidentical stem cell transplantation","volume":"209","author":"Shmueli","year":"2014","journal-title":"J. Infect. Dis."},{"key":"B27","doi-asserted-by":"publisher","first-page":"7673","DOI":"10.1128\/JVI.00578-15","article-title":"High-throughput analysis of human cytomegalovirus genome diversity highlights the widespread occurrence of gene-disrupting mutations and pervasive recombination","volume":"89","author":"Sijmons","year":"2015","journal-title":"J. Virol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.1093\/molbev\/mst197","article-title":"MEGA6: molecular evolutionary genetics analysis version 6.0","volume":"30","author":"Tamura","year":"2013","journal-title":"Mol. Biol. Evol."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1002\/0471250953.bi0203s00","article-title":"Multiple sequence alignment using ClustalW and ClustalX","author":"Thompson","year":"2002","journal-title":"Curr. Protoc."},{"key":"B30","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3851\/IMP1899","article-title":"Failure of pre-emptive treatment of cytomegalovirus infections and antiviral resistance in stem cell transplant recipients","volume":"17","author":"van der Beek","year":"2012","journal-title":"Antivir. Ther."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"deposited":{"date-parts":[[2016,10,4]],"date-time":"2016-10-04T13:02:24Z","timestamp":1475586144000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/Article\/10.3389\/fmicb.2016.01317\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,9]]},"references-count":30,"URL":"https:\/\/doi.org\/10.3389\/fmicb.2016.01317","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/055814","asserted-by":"object"}]},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,9]]}}}